🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Philip H. Abbosh

Fox Chase Cancer Center

ORCID: 0000-0003-3611-9532

Also affiliated with Einstein Healthcare Network, Cancer Research Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).

53 citations

Philip H. Abbosh, Eric A. Ross, Matthew R. Zibelman, Pooja Ghatalia, Fern Anari +14 more

3 citations

Henkel Valentine, David Liu, Michael J. Slifker, Costas D. Lallas, Edouard J. Trabulsi +24 more

3 citations

Nagib Ahsan, Amriti R. Lulla, Avital Lev, Philip H. Abbosh, David T. Dicker +3 more

28 citations

Nagib Ahsan, Amriti R. Lulla, Avital Lev, Philip H. Abbosh, David T. Dicker +3 more

26 citations

Megan Prunty, Ilaha Isali, Adam Calaway, Rashida Ginwala, Mohit Sindhani +7 more

7 citations

Rashida Ginwala, Mohit Sindhani, Megan Prunty, Daniel M. Geynisman, Pooja Ghatalia +15 more